The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.
about
Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agentsIncidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel.Current state and controversies in fertility preservation in women with breast cancer.Melatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.Estimates of young breast cancer survivors at risk for infertility in the U.S.Prospective study of fertility concerns and preservation strategies in young women with breast cancerThe feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy induced ovarian failure in patient with gynecological malignanciesChallenges in the gynecologic care of premenopausal women with breast cancer.The psychosocial impact of interrupted childbearing in long-term female cancer survivors.Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer.Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment.Opportunities for public health communication, intervention, and future research on breast cancer in younger women.Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular ToxicityChemotherapy-Induced Amenorrhea - An UpdateChemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levelsEmbryo banking among women diagnosed with cancer: a pilot population-based study in New York, Texas, and Illinois.Premature menopause in young breast cancer: effects on quality of life and treatment interventions.Challenges in managing breast cancer during pregnancy.Oncofertility in Canada: the impact of cancer on fertilityChemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).Long-term toxic effects of adjuvant chemotherapy in breast cancer.Motherhood after breast cancer: searching for la dolce vita.Pregnancy after breast cancer: if you wish, ma'am.Trastuzumab administration during pregnancy: a systematic review and meta-analysis.Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.Fertility issues in cancer survivorship.New insights into endocrine therapy for young women with breast cancer.The evolving understanding of small HER2-positive breast cancers: matching management to outcomes.Unintended pregnancy during the first year after breast cancer diagnosis.GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.Impact of Fertility Concerns on Tamoxifen Initiation and Persistence.Fertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines.Vitrification of embryos and oocytes for fertility preservation in cancer patients.Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).Sexuality, fertility and pregnancy following breast cancer treatment
P2860
Q26771340-96A950E3-AE47-4796-BC27-D8C538897C25Q28240178-0B8128B0-ABB2-484D-8363-A4EA7587482EQ33320772-86758DA4-C173-4002-B534-286B6F37DFCEQ33779879-B7CCCDBA-A672-41E3-8F91-416AA8172361Q33838766-418C6443-DF14-4A2F-BC81-24EE8D0C52C5Q34005150-4C31183B-C96F-4BA5-8AF1-1E15E00FAA03Q34184805-BD5B9EDE-CFB4-4D35-9A05-85B2B472CB3FQ34577007-59980990-BE23-452A-A198-53D628B72CA8Q34616059-B03CCC64-DF48-4BAC-99BB-C2CD71CB86B5Q35069536-4A6EA00C-ED56-4DDE-AAB4-92B892854262Q35075441-BC2E768A-9A85-42FE-B849-C5BFF2901824Q35100279-42EEBDC2-A7FD-4636-8A11-8937212A520FQ35160902-2064B812-4B00-40AC-A10D-50C27A6F2C5FQ35800077-B4126296-04B0-40C8-B517-A06F56C6E8BAQ36064942-3D31FE6F-D341-4826-B491-62E3E83B4B6FQ36295133-61ED6D9B-AC12-4B2D-9E41-AD691D9F15FCQ36405634-85220723-B72D-44E0-9FDD-2F34D72DDBE1Q36490058-CF364103-0B7A-4598-835A-6CADB03C2208Q36713321-2633D73B-7A4A-4F65-B51C-4BC58E252F75Q36885123-FDCBC6DC-AA5F-4FA8-9F01-9F7A20F119B7Q36910180-FA2F5B7C-645A-4603-8E85-090E1CF688A6Q36963345-B9AEBEC9-1FAA-487A-8E57-7C9E6FDB8C02Q36963370-0BB6DEEE-C7E6-453C-9D59-95E68F7965ADQ37056902-5367041C-9715-43DF-869D-FCC6CEA43DFEQ37325544-BA47CDD8-E63C-4551-BC7F-06863C6C0F8DQ37834884-D943CAE6-396D-477C-BE84-48898E113935Q37845835-5106632D-99BD-4490-9EB6-D60A0E0D0E8CQ37893531-0905965E-E734-4D71-A5C2-0907BB9AEEF4Q38067635-45707C93-9D4B-49E7-BA23-0A2FF47C0ACAQ38109554-E47CBEF3-FBD0-4504-8E92-E1216FA6ACBCQ38194105-CCDBDD51-CBD9-47EF-B5FE-49E9F9F4E019Q38535371-ACBC0262-B5C6-4637-8F0C-4968C023F3F8Q38658647-0380766A-FFFE-4D2E-890B-E03D901C58BFQ39734584-90EF9FDA-5ACA-476C-8869-51CE35C75E94Q40432160-66F39E5D-768E-49FD-ABCC-C269F506A22FQ40606927-F131CF74-059F-421E-B4B5-3FAB64358668Q48502529-094F78E0-21C8-4CFC-9EA5-5A1628F76264Q48556557-D3CB3316-B51B-4BE7-B004-4A0777106D56Q53655466-64842E2D-2FB7-4F00-8D9C-64647DA664B4Q57108701-41D1222E-1335-43E8-84F4-41B696FD0F8E
P2860
The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effects of paclitaxel, dos ...... usal women with breast cancer.
@en
The effects of paclitaxel, dos ...... usal women with breast cancer.
@nl
type
label
The effects of paclitaxel, dos ...... usal women with breast cancer.
@en
The effects of paclitaxel, dos ...... usal women with breast cancer.
@nl
prefLabel
The effects of paclitaxel, dos ...... usal women with breast cancer.
@en
The effects of paclitaxel, dos ...... usal women with breast cancer.
@nl
P2093
P356
P1433
P1476
The effects of paclitaxel, dos ...... usal women with breast cancer.
@en
P2093
Ann H Partridge
Elizabeth S Ginsburg
Jane C Weeks
Mary E Abusief
P304
P356
10.1002/CNCR.24835
P407
P577
2010-02-01T00:00:00Z